Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases
New Commitment to Action will apply Seek Labs’ BioSeeker AI and Sequence Ablation Therapeutics platform to diseases historically underserved by traditional therapeutic development SALT LAKE CITY, Sept.
22, 2026 (GLOBE NE
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.